Visagar Financial [VISAGAR] vs Authum Investment [AIIL] Detailed Stock Comparison
Visagar Financial
BSE
Loading...
Authum Investment
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Visagar Financial wins in 3 metrics, Authum Investment wins in 15 metrics, with 0 ties. Authum Investment appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Visagar Financial | Authum Investment | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.00 | 12.47 | Authum Investment |
| Price-to-Book Ratio | 0.46 | 3.46 | Visagar Financial |
| Debt-to-Equity Ratio | 72.41 | 7.18 | Authum Investment |
| PEG Ratio | -0.48 | -0.89 | Authum Investment |
| EV/EBITDA | 20.73 | 11.61 | Authum Investment |
| Profit Margin (TTM) | 1.35% | 93.88% | Authum Investment |
| Operating Margin (TTM) | -41.22% | 96.55% | Authum Investment |
| EBITDA Margin (TTM) | N/A | 96.55% | N/A |
| Return on Equity | -0.27% | 28.87% | Authum Investment |
| Return on Assets (TTM) | -0.15% | 26.36% | Authum Investment |
| Free Cash Flow (TTM) | $2.65M | $2.53B | Authum Investment |
| Dividend Yield | N/A | 0.06% | N/A |
| 1-Year Return | -37.66% | 74.02% | Authum Investment |
| Price-to-Sales Ratio (TTM) | 0.28 | 11.73 | Visagar Financial |
| Enterprise Value | $689.52M | $526.50B | Authum Investment |
| EV/Revenue Ratio | 0.68 | 12.09 | Visagar Financial |
| Gross Profit Margin (TTM) | -838.00% | 97.25% | Authum Investment |
| Revenue per Share (TTM) | $2 | $256 | Authum Investment |
| Earnings per Share (Diluted) | $0.02 | $240.78 | Authum Investment |
| Beta (Stock Volatility) | 0.38 | -0.73 | Authum Investment |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Visagar Financial vs Authum Investment Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Visagar Financial | 2.08% | -4.00% | 0.00% | -9.43% | -12.73% | -37.66% |
| Authum Investment | 1.41% | -6.17% | -5.13% | 12.06% | 93.07% | 57.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Visagar Financial | -37.66% | -68.42% | -20.00% | -44.83% | -98.61% | 118.18% |
| Authum Investment | 74.02% | 247.21% | 247.21% | 247.21% | 247.21% | 247.21% |
News Based Sentiment: Visagar Financial vs Authum Investment
Visagar Financial
News based Sentiment: NEGATIVE
The month was dominated by disappointing financial results, despite some reduction in losses. The upcoming AGM and potential related-party loan approvals add significant uncertainty, making this a crucial period for the company and its investors. While search interest increased, the overall narrative remains negative due to the continued financial struggles.
Authum Investment
News based Sentiment: NEGATIVE
September proved to be a challenging month for Authum, with a CBI chargesheet, declining profitability, a stock downgrade, and insider selling overshadowing the strategic investment in Serovia Pharma. These negative developments significantly increase the risk profile of the investment, making it a critical period for the company.
Performance & Financial Health Analysis: Visagar Financial vs Authum Investment
| Metric | VISAGAR | AIIL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹280.28M | ₹504.41B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 1,169,261 | 260,590 |
| 90 Day Avg. Volume | 1,092,312 | 274,744 |
| Last Close | ₹0.49 | ₹3,007.30 |
| 52 Week Range | ₹0.44 - ₹0.80 | ₹1,325.50 - ₹3,295.00 |
| % from 52W High | -38.75% | -8.73% |
| All-Time High | ₹80.00 (May 07, 2012) | ₹3,295.00 (Sep 16, 2025) |
| % from All-Time High | -99.39% | -8.73% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.92% | -0.15% |
| Quarterly Earnings Growth | -0.99% | -0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.94% |
| Operating Margin (TTM) | -0.41% | 0.97% |
| Return on Equity (TTM) | 0.00% | 0.29% |
| Debt to Equity (MRQ) | 72.41 | 7.18 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹1.04 | ₹866.73 |
| Cash per Share (MRQ) | ₹0.01 | ₹21.74 |
| Operating Cash Flow (TTM) | ₹1.10M | ₹70.10B |
| Levered Free Cash Flow (TTM) | ₹-1,607,000 | ₹42.41B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.06% |
| Last 12-Month Dividend | N/A | ₹1.50 |
Valuation & Enterprise Metrics Analysis: Visagar Financial vs Authum Investment
| Metric | VISAGAR | AIIL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.00 | 12.47 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.48 | -0.89 |
| Price to Sales (TTM) | 0.28 | 11.73 |
| Price to Book (MRQ) | 0.46 | 3.46 |
| Market Capitalization | ||
| Market Capitalization | ₹280.28M | ₹504.41B |
| Enterprise Value | ₹689.52M | ₹526.50B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.68 | 12.09 |
| Enterprise to EBITDA | 20.73 | 11.61 |
| Risk & Other Metrics | ||
| Beta | 0.38 | -0.73 |
| Book Value per Share (MRQ) | ₹1.04 | ₹866.73 |
Financial Statements Comparison: Visagar Financial vs Authum Investment
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VISAGAR | AIIL |
|---|---|---|
| Revenue/Sales | ₹3.32M | ₹12.15B |
| Cost of Goods Sold | ₹31.12M | ₹334.70M |
| Gross Profit | ₹-27.81M | ₹11.82B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-10.51M | ₹11.34B |
| EBITDA | ₹-10.27M | ₹11.37B |
| Pre-Tax Income | ₹-10.51M | ₹11.44B |
| Income Tax | ₹0 | ₹2.01B |
| Net Income (Profit) | ₹-10.51M | ₹9.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VISAGAR | AIIL |
|---|---|---|
| Cash & Equivalents | ₹6.47M | ₹1.08B |
| Total Current Assets | ₹104.76M | ₹32.75B |
| Total Current Liabilities | ₹438.30M | ₹10.38B |
| Long-Term Debt | ₹0 | ₹3.60B |
| Total Shareholders Equity | ₹605.43M | ₹146.89B |
| Retained Earnings | ₹-5.99M | ₹28.29B |
| Property, Plant & Equipment | ₹5.31M | ₹21.90M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VISAGAR | AIIL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VISAGAR | AIIL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,169,261 | 260,590 |
| Average Daily Volume (90 Day) | 1,092,312 | 274,744 |
| Shares Outstanding | 583.92M | 169.85M |
| Float Shares | 480.33M | 33.92M |
| % Held by Insiders | 0.06% | 0.84% |
| % Held by Institutions | 0.00% | 0.04% |
Dividend Analysis & Yield Comparison: Visagar Financial vs Authum Investment
| Metric | VISAGAR | AIIL |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.50 |
| Last 12-Month Dividend Yield | N/A | 0.06% |
| 3-Year Avg Annual Dividend | N/A | ₹0.50 |
| 3-Year Avg Dividend Yield | N/A | 0.04% |
| 3-Year Total Dividends | N/A | ₹1.50 |
| Ex-Dividend Date | N/A | May 16, 2025 |